As of close of business last night, Akero Therapeutics Inc’s stock clocked out at $23.22, up 1.09% from its previous closing price of $22.97. In other words, the price has increased by $+0.25 from its previous closing price. On the day, 531805 shares were traded.
Ratios:
To gain a deeper understanding of AKRO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 29.27 and its Current Ratio is at 29.27. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on September 19, 2023, initiated with a Overweight rating and assigned the stock a target price of $69.
On August 28, 2023, UBS started tracking the stock assigning a Buy rating and target price of $83.
Morgan Stanley Upgraded its Equal-Weight to Overweight on January 27, 2023, whereas the target price for the stock was revised from $40 to $65.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 01 ’24 when Young Jonathan sold 5,000 shares for $24.38 per share. The transaction valued at 121,913 led to the insider holds 263,306 shares of the business.
Cheng Andrew sold 1,969 shares of AKRO for $55,782 on Mar 13 ’24. The President and CEO now owns 589,447 shares after completing the transaction at $28.33 per share. On Mar 13 ’24, another insider, White William Richard, who serves as the Chief Financial Officer of the company, sold 724 shares for $28.33 each. As a result, the insider received 20,511 and left with 49,630 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AKRO now has a Market Capitalization of 1.60B and an Enterprise Value of 1.08B.
Stock Price History:
Over the past 52 weeks, AKRO has reached a high of $58.38, while it has fallen to a 52-week low of $11.25. The 50-Day Moving Average of the stock is 24.42, while the 200-Day Moving Average is calculated to be 30.71.
Shares Statistics:
It appears that AKRO traded 1.40M shares on average per day over the past three months and 859.39k shares per day over the past ten days. A total of 68.95M shares are outstanding, with a floating share count of 57.62M. Insiders hold about 16.43% of the company’s shares, while institutions hold 82.89% stake in the company. Shares short for AKRO as of Mar 15, 2024 were 9.47M with a Short Ratio of 6.76, compared to 8.89M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 13.74% and a Short% of Float of 14.04%.
Earnings Estimates
As of right now, 6 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$1 for the current quarter, with a high estimate of -$0.79 and a low estimate of -$1.15, while EPS last year was -$0.55. The consensus estimate for the next quarter is -$1, with high estimates of -$0.8 and low estimates of -$1.2.
Analysts are recommending an EPS of between -$2.89 and -$5.1 for the fiscal current year, implying an average EPS of -$3.97. EPS for the following year is -$4.33, with 7 analysts recommending between -$3.36 and -$5.4.
